SDGII-T200801

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSDGII-T200801
Drug Alias NameTAU/beta amyloid-targeting compound (Bioalvo)SDGII-T200801
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule-associated protein tau inhibitorsBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 proteinMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPortugal
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioalvo SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioalvo SA
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A